Main Sequence was founded by CSIRO in 2017 to address the ‘valley of death’ between research and commercialisation.
Main Sequence’s origins within CSIRO reflect its commitment to amplifying connections between industry, research and infrastructure to accelerate deep technology development, and reinvesting economic returns from commercialisation back into science.
CSIRO Innovation Funds 1 and 2 managed by Main Sequence, have invested in 51 companies since establishment in 2017. These companies have created over 2100 jobs by working with partners in industry, CSIRO, and 28 Australian universities.
The $240 million first CSIRO Innovation Fund, built on a cornerstone investment by government and CSIRO has completed its portfolio and invested in 27 companies since establishment in 2017.
The second $300 million CSIRO Innovation Fund commenced investing mid-2021 and had already invested in 12 companies by the end of 2021.
Fund 3 has raised $450 million, surpassing $1 billion in total funds under management.
Learn more about Main Sequence